Canada markets closed

Kura Oncology, Inc. (KUR.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
21.00+1.09 (+5.50%)
At close: 08:01AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
126,311
115,235
92,812
84,721
60,397
Selling General and Administrative
57,379
50,569
47,053
46,537
31,502
Total Operating Expenses
183,690
165,804
139,865
131,258
91,899
Operating Income or Loss
-183,690
-165,804
-139,865
-131,258
-91,899
Interest Expense
1,583
1,549
229
414
578
Total Other Income/Expenses Net
-
-
-
-
51
Income Before Tax
-168,087
-152,631
-135,840
-130,466
-89,625
Income from Continuing Operations
-168,087
-152,631
-135,840
-130,466
-89,625
Net Income
-168,087
-152,631
-135,840
-130,466
-89,625
Net Income available to common shareholders
-168,087
-152,631
-135,840
-130,466
-89,625
Basic EPS
-2.03
-2.08
-2.03
-1.97
-1.69
Diluted EPS
-2.03
-2.08
-2.03
-1.97
-1.69
Basic Average Shares
66,990
73,229
66,990
66,352
53,077
Diluted Average Shares
66,990
73,229
66,990
66,352
53,077